Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 31, 2025 05:20 ET | Source: Research and Markets

Spine Biologics Market Research to 2030: Expansion Fueled by Patient Education and Awareness Campaigns, Favorable Reimbursement Policies, and Strategic Alliances and Collaborations

Dublin, Jan. 31, 2025 (GLOBE NEWSWIRE) -- The "Spine Biologics Market by Product, by End-user, and by Region" report has been added to ResearchAndMarkets.com's offering.The global spine biologics...
July 16, 2024 10:40 ET | Source: Straits Research Private Limited - Garner Insights

Spinal Implants and Devices Market Poised for Significant Growth, Expected to Reach USD 22.39 Billion by 2032, According to Straits Research

New York, United States, July 16, 2024 (GLOBE NEWSWIRE) -- As per the Latest Report by Straits Research, the global spinal implants and devices market size was valued at USD 13.97 billion in...
November 16, 2023 10:15 ET | Source: Emergen Research

Spinal Implants and Surgery Devices Market Size Worth USD 18.41 Billion in 2032 | Emergen Research

Vancouver, Nov. 16, 2023 (GLOBE NEWSWIRE) -- The global spinal implants and surgery devices market is projected to be worth USD 18.41 Billion by 2032, according to a current analysis by Emergen...
September 22, 2023 06:33 ET | Source: Research and Markets

Global Spine Biologics Market 2023-2030: Rising Demand for Minimally Invasive Procedures: A Key Driver for the Spine Biologics Market

Dublin, Sept. 22, 2023 (GLOBE NEWSWIRE) -- The "Global Spine Biologics Market by Product (Bone Graft Substitutes, Cell-Base Matrix, Spinal Allografts), Application (Non-Fusion, Spinal Fusion),...
June 19, 2023 12:30 ET | Source: Transparency Market Research

Spine Biologics Market to Surpass USD 3.5 billion in 2033, expected to expand at a 4.2% CAGR: TMR Report

Wilmington, Delaware, United States, June 19, 2023 (GLOBE NEWSWIRE) -- The global spine biologics market is anticipated to be valued at US$ 3.5 billion by 2031, expected to incline at a CAGR of 4.2%...